• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, January 20, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The making of memory B cells and long-term immune responses

Bioengineer by Bioengineer
October 12, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Only B cells that express Bach2 and reduced mTORC1 activity can become memory B cells, the body’s first responder to re-infections

IMAGE

Credit: Osaka University

Osaka, Japan — The current COVID-19 climate has made vaccines, antibodies, and immune responses topics of everyday conversation. Now, it isn’t just immunologists who want to know how our bodies respond to re-infections months, years, or sometimes decades after an initial immune response. A new study by Tomohiro Kurosaki at Osaka University shows that this ability requires Bach2, a protein that regulates the expression of genes needed to instruct activated B cells under selection to become memory B cells.

Like most biological processes, immune responses are complicated. They involve numerous types of cells and proteins, performing precise step-by-step processes. And of course, we don’t know all of them yet. For example, memory B cells are a type of white blood cell that are created in lymph nodes or spleens during an infection. They stick around for years and allow rapid and strong antibody-related responses to re-infection by the same virus or bacteria. In contrast, plasma cells are much more numerous and help during an initial infection by producing antibodies, although they too can exist for long periods of time in the body. Kurosaki and his team focused their research on understanding what causes activated B cells, called germinal center B cells, to become memory B cells, plasma cells, or to be recycled.

Scientists can identify different types of B cells by markers–certain proteins–that they express. On the basis of specific markers, the researchers identified a subset of B cells that they determined were prone to become memory B cells, which they called pro-memory B cells. They then examined mice lacking the protein Bach2, a transcription factor required for memory B cell production. These mice are known to be deficient in producing memory B cells. The researchers found that the lack of Bach2 was associated with fewer pro-memory B cells and increased expression of genes related to a protein complex called mTORC1.

Further testing showed the importance of mTORC1. “We ultimately found that mTORC1 signaling was less active in pro-memory B cells than in those that ended up being recycled,” says Kurosaki. Inhibiting mTORC1 activity (in other words, inducing a state of mTORC1 hypometabolism) in the Bach2 knockout mice rescued them, allowing the mice to produce memory B cells. Additionally, in wild-type mice, artificially reducing mTORC1 activity in B cells led to the production of more memory B cells than normal, while increasing its activity had the opposite effect. However, mTORC1 activity alone could not explain everything. Experiments showed that the unique combination of Bach2 expression and reduced mTORC1 activity is necessary to become memory B cells.

Understanding the process through which memory B cells are produced means that this process can be manipulated for our benefit. “Given the importance of memory B cells in protecting us against re-infection, being able to induce their production could be helpful for developing efficient vaccines that remain effective for years,” says Kurosaki.

###

The article, “Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal,” was published in Journal of Experimental Medicine at DOI: https://doi.org/10.1084/jem.20200866

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan’s leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan’s most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.

Website: https://resou.osaka-u.ac.jp/en/top

Media Contact
Saori Obayashi
[email protected]

Original Source

https://resou.osaka-u.ac.jp/en/top

Related Journal Article

http://dx.doi.org/10.1084/jem.20200866

Tags: BiologyImmunology/Allergies/AsthmaMedicine/HealthMolecular BiologyVaccines
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Genome editing to treat human retinal degeneration

January 19, 2021
IMAGE

Individual and organizational capacity to change can reduce health care workforce burnout

January 19, 2021

Brain cell network supplies neurons with energy

January 19, 2021

Lack of physical exercise during COVID-19 confinement may lead to a rise in mortality

January 19, 2021
Next Post
IMAGE

When it comes to arthritic bone spurs, stem cells hurt instead of heal

IMAGE

The unending waste management challenge - are we at our wits' end?

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsPublic HealthClimate ChangeChemistry/Physics/Materials SciencesBiologyInfectious/Emerging DiseasesMedicine/HealthTechnology/Engineering/Computer ScienceEcology/EnvironmentGeneticscancerCell Biology

Recent Posts

  • Genome editing to treat human retinal degeneration
  • Do simulations represent the real world at the atomic scale?
  • Protected areas vulnerable to growing emphasis on food security
  • Constructing termite turrets without a blueprint
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In